|
1
|
Mamelak AN and Jacoby DB: Targeted
delivery of antitumoral therapy to glioma and other malignancies
with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv.
4:175–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Glass LR, Canoll P, Lignelli A, Ligon AH
and Kazim M: Optic nerve glioma: Case series with review of
clinical, radiologic, molecular, and histopathologic
characteristics. Ophthal Plast Reconstr Surg. 30:372–376. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Diamond EL, Corner GW, De Rosa A,
Breitbart W and Applebaum AJ: Prognostic awareness and
communication of prognostic information in malignant glioma: A
systematic review. J Neurooncol. 119:227–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: A “state of the
science” review. Neurooncol. 16:896–913. 2014.
|
|
6
|
Englot DJ, Berger MS, Chang EF and Garcia
PA: Characteristics and treatment of seizures in patients with
high-grade glioma: A review. Neurosurg Clin N Am. 23:227–235,
vii-viii. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alexander H, Irwin C, Purdie G and Hunn M:
Incidence and management of high grade glioma in Mãori and
non-Mãori patients. J Clin Neurosci. 17:1144–1147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hess KR, Broglio KR and Bondy ML: Adult
glioma incidence trends in the United States, 1977–2000. Cancer.
101:2293–2299. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuijlen JM, Bremer E, Mooij JJ, den Dunnen
WF and Helfrich W: Review: On TRAIL for malignant glioma therapy?
Neuropathol Appl Neurobiol. 36:168–182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Walter F, la Fougère C, Belka C and Niyazi
M: Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy
Planning in Malignant Glioma Patients - A Review. Front Oncol.
2:1302012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stylli SS and Kaye AH: Photodynamic
therapy of cerebral glioma - a review. Part II - clinical studies.
J Clin Neurosci. 13:709–717. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tobias A, Ahmed A, Moon KS and Lesniak MS:
The art of gene therapy for glioma: A review of the challenging
road to the bedside. J Neurol Neurosurg Psychiatry. 84:213–222.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carpentier AF, Auf G and Delattre JY:
CpG-oligonucleotides for cancer immunotherapy: Review of the
literature and potential applications in malignant glioma. Front
Biosci. 8:e115–127. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barker N: The canonical Wnt/beta-catenin
signalling pathway. Methods Mol Biol. 468:5–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lugli A, Zlobec I, Minoo P, Baker K,
Tornillo L, Terracciano L and Jass JR: Prognostic significance of
the wnt signalling pathway molecules APC, beta-catenin and
E-cadherin in colorectal cancer: A tissue microarray-based
analysis. Histopathology. 50:453–464. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu L, Zhang C, Zhang LY, Dong SS, Lu LH,
Chen J, Dai Y, Li Y, Kong KL, Kwong DL, et al: Wnt2 secreted by
tumour fibroblasts promotes tumour progression in oesophageal
cancer by activation of the Wnt/β-catenin signalling pathway. Gut.
60:1635–1643. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matono H, Tamiya S, Yokoyama R, Saito T,
Iwamoto Y, Tsuneyoshi M and Oda Y: Abnormalities of the
Wnt/β-catenin signalling pathway induce tumour progression in
sporadic desmoid tumours: Correlation between β-catenin widespread
nuclear expression and VEGF overexpression. Histopathology.
59:368–375. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Caspi M, Zilberberg A, Eldar-Finkelman H
and Rosin-Arbesfeld R: Nuclear GSK-3beta inhibits the canonical Wnt
signalling pathway in a beta-catenin phosphorylation-independent
manner. Oncogene. 27:3546–3555. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weng X, Lin P, Liu F, Chen J, Li H, Huang
L, Zhen C, Xu H, Liu X, Ye H and Li X: Achyranthes bidentata
polysaccharides activate the Wnt/β-catenin signaling pathway to
promote chondrocyte proliferation. Int J Mol Med. 34:1045–1050.
2014.PubMed/NCBI
|
|
20
|
Petersen CP and Reddien PW:
Smed-betacatenin-1 is required for anteroposterior blastema
polarity in planarian regeneration. Science. 319:327–330. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Torday JS and Rehan VK: Up-regulation of
fetal rat lung parathyroid hormone-related protein gene regulatory
network down-regulates the Sonic Hedgehog/Wnt/betacatenin gene
regulatory network. Pediatr Res. 60:382–388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Du R, Xia L, Sun S, Lian Z, Zou X, Gao J,
Xie H, Fan R, Song J, Li X, et al: URG11 promotes gastric cancer
growth and invasion by activation of beta-catenin signalling
pathway. J Cell Mol Med. 14:621–635. 2010.PubMed/NCBI
|
|
23
|
Bilmin K, Kopczyńska B and Grieb P:
Influence of serum and albumin on the in vitro anandamide
cytotoxicity toward C6 glioma cells assessed by the MTT cell
viability assay: Implications for the methodology of the MTT tests.
Folia Neuropathol. 51:44–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cookson MR, Mead C, Austwick SM and
Pentreath VW: Use of the MTT assay for estimating toxicity in
primary astrocyte and C6 glioma cell cultures. Toxicol In Vitro.
9:39–48. 1995. View Article : Google Scholar : PubMed/NCBI
|
